Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Align Research update note

12 Oct 2017 07:00

RNS Number : 3758T
Obtala Limited
11 October 2017
 

Obtala Limited - Conviction Buy. Target price 38.18p

Step change in revenues evident following interims & Q3 update

Obtala Limited is an Africa focussed forestry and agriculture company with a goal of becoming one of Sub-Saharan Africa's largest sustainable food and timber producers.

Interims show period of investment & Woodbois value made apparent

Obtala posted an operating loss of $3.8 million for the six months to 30th June 2017 but a statutory profit of $22.7 million following a gain on the acquisition of Woodbois. An independent valuation of the forestry and timber trading firm added $53.3 million to Obtala's biological asset value. This compares to a revised purchase price for Woodbois of $12.2 million.

Q3 update shows further progress and additional funds raised

The three months to September 2017 saw the end of the forestry close cutting season in Mozambique, the first significant harvests from the agriculture division and the first contribution from the Woodbois acquisition. An additional $2 million has also been raised to support growth via a further preference share in the forestry subsidiary Argento Limited.

Corporate structure re-organised with new Boards appointed

Obtala will now report to the markets via the three divisions of Timber Trading, Timber Production (together the Forestry division) and Agriculture Production. To support this, new boards have been appointed to the Argento (forestry) and Montara (agriculture) subsidiaries.

DCF derived target price of 38.18p suggests 117% upside

Obtala is now seeing a step change in revenue and profit growth across the three divisions of the business. Nevertheless, the shares trade at a substantial discount to net assets, with the market cap c.90% covered by Obtala's stake in Argento alone. Our DCF analysis suggests a target price of 38.18p, therefore we retain our stance of Conviction Buy.

To download the full note visit http://www.alignresearch.co.uk/cpt-company/obtala/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMBBPTMBBBBBR
Date   Source Headline
27th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
24th Jun 20247:00 amRNS$5m Trade Finance Facility Completed
12th Jun 20247:00 amRNSBoard Changes & Trading Update
10th Jun 20247:00 amRNSUpdate on Publication of Financial Statements
23rd May 20241:43 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSMozambique Operations to be Divested
8th Feb 20247:05 amRNS£2.0m Exercise of Warrants to scale-up production
8th Feb 20247:00 amRNS$5m Trade Finance, Gabon Progress & 2024 Outlook
12th Jan 20247:00 amRNSIssuance of Shares and Warrants
5th Jan 20247:00 amRNSCEO Departure Commences Restructuring
29th Dec 202312:27 pmRNSResults of Annual General Meeting
29th Dec 20237:00 amRNSBoard Change, Strategic Initiatives & Joint Broker
4th Dec 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSNotice of Annual General Meeting
29th Sep 20237:00 amRNSHalf Year Results
30th Aug 20239:05 amRNSStatement re Share Price Movement
29th Jun 20231:30 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSSubscription, Debt Refinancing & Issue of Warrants
16th Jun 202312:00 pmRNSResults of General Meeting
9th Jun 20237:00 amRNSAudited results for FY 2022
6th Jun 20237:00 amRNSDebt Repayment Terms and Corporate Update
30th May 20237:00 amRNSNotice of General Meeting and Posting of Circular
19th Apr 202311:45 amRNSTR-1
19th Apr 20237:14 amRNSFacility with Sydbank A/S ("Sydbank")
11th Apr 20237:01 amRNSQ1 2023 Update
11th Apr 20237:00 amRNSConditional Award of Afforestation Project
13th Mar 20237:00 amRNSPlacing of £3 million
10th Mar 20231:00 pmRNSTR-1
10th Mar 202312:41 pmRNSResponse to market speculation
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 202310:40 amRNSTR-1
24th Feb 202311:15 amRNSTR-1
31st Jan 20231:45 pmRNSTR-1
12th Jan 20237:00 amRNSQ4 2022 update
5th Dec 20225:30 pmRNSTR-1
11th Nov 20227:00 amRNSConversion of 55 million Non-Voting Shares
1st Nov 20228:15 amRNSTR-1
27th Oct 20225:15 pmRNSConversion of 60 million Non-Voting Shares
21st Oct 20227:00 amRNSTR-1
17th Oct 20227:00 amRNSQ3 2022 Upate an Boar change
17th Oct 20227:00 amRNSQ3 2022 Update and Board change
26th Sep 20224:15 pmRNSTR-1
26th Sep 20227:00 amRNSConversion of 60 million Non-Voting Shares
17th Aug 20227:00 amRNSEighth Ranking in SPOTT Transparency Assessment
10th Aug 20229:00 amRNSExercise of Options
4th Aug 20227:00 amRNSHalf Year Results
11th Jul 20227:00 amRNSQ2 2022 update
27th Jun 20227:00 amRNSConversion of 65 million Non-Voting Shares
16th Jun 20227:00 amRNSConversion of $243,591 of Convertible Bonds
14th Jun 20227:00 amRNSConversion of $50,000 of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.